Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
Runx1t1
REST API REST API
Mus musculus
Runx1t1 is differentially expressed in 240 experiments: 116 organism parts: liver, kidney, ... (114 more);, 17 disease states: normal, 3-NP-induced neurodegeneration model of Huntington's disease, ... (15 more);, 69 cell types 16 cell lines 30 compound treatments and 41 other conditions.
Synonyms 'ETO', 'Cbfa2t1h', 'MTG8'
Orthologs RUNX1T1 (Gallus gallus)   RUNX1T1 (Homo sapiens)   Runx1t1 (Rattus norvegicus)   RUNX1T1 (Bos taurus)   nvy (Drosophila melanogaster)   runx1t1 (Xenopus laevis)   (Compare orthologs)
Gene Ontology Term protein binding, regulation of transcription, DNA-dependent, regulation of DNA binding, transcription, DNA-dependent, metal ion binding, identical protein binding, nucleus, protein homodimerization activity, zinc ion binding, fat cell differentiation, sequence-specific DNA binding transcription factor activity
InterPro Term Znf_MYND, MTG8, ETO, TAFH_NHR1, NHR2
Search EB-eye ENSMUSG00000006586
Show more properties
Experimental Factors
Organism part

studied in E-TABM-1039, E-GEOD-1479, E-GEOD-20160, E-GEOD-3963, E-GEOD-2866, ... (57 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-21515, E-GEOD-19732, E-GEOD-10246, E-MEXP-1361, E-MEXP-2554, ... (6 experiments)

Factor Value U/D Experiments
66cl4
1
1
E-GEOD-11259
min6
1
E-GEOD-10246
14M1.4
1
E-MEXP-2554
IP14D-101
1
1
E-GEOD-21515
IP20D-3
1
E-GEOD-21515
IP36D-3
1
E-GEOD-21515
10 more value(s).


Cell type

studied in E-GEOD-19401, E-GEOD-7764, E-GEOD-7069, E-GEOD-21749, E-TABM-130, ... (19 experiments)

Factor Value U/D Experiments
hematopoietic stem cell
1
2
E-GEOD-7069, E-GEOD-6623, E-GEOD-20377
dorsal root ganglion
1
E-GEOD-10246
testis
1
E-GEOD-10246
mesenchymal cell
1
E-GEOD-12618
inner medullary collecting duct
1
E-GEOD-10246
primary osteoblast
1
E-GEOD-4768
63 more value(s).


Disease state

studied in E-MEXP-1296, E-GEOD-21927, E-GEOD-6461, E-GEOD-2514, E-MEXP-1137, ... (11 experiments)

Factor Value U/D Experiments
breast carcinoma
1
E-GEOD-2528
MMTV-Myc
1
E-GEOD-15904
prostate carcinoma
1
E-MEXP-1296
synovial sarcoma
1
E-GEOD-6461
myocardial infarction
1
E-GEOD-775
bronchoalveolar adenocarcinoma
1
E-MEXP-1137
11 more value(s).


Compound treatment

studied in E-TABM-903, E-GEOD-3296, E-TABM-310, E-GEOD-3858, E-GEOD-2973, ... (27 experiments)

Factor Value U/D Experiments
control
3
7
E-GEOD-21710, E-GEOD-21361, E-TABM-903, E-GEOD-5324, E-GEOD-2411, ... (10 experiments)
none
3
5
E-MEXP-2282, E-MEXP-1137, E-GEOD-4696, E-TABM-363, E-TABM-141, ... (8 experiments)
lipopolysaccharide
1
3
E-GEOD-2411, E-GEOD-10246, E-TABM-310, E-GEOD-3565
trichostatin A and dipyridyl
1
E-GEOD-3296
IDMB
1
E-GEOD-1123
human chorionic gonadotrophin
1
E-GEOD-4260
24 more value(s).


Agent

studied in E-GEOD-32706

Factor Value U/D Experiments
fenofibrate
1
1
E-GEOD-32706


Amount to core
studied in E-GEOD-18858

Biosource provider
studied in E-GEOD-14906

cell population
studied in E-GEOD-26086

Clinical info
studied in E-MEXP-1458

Clinical treatment
studied in E-GEOD-3075, E-GEOD-2411

Cohort
studied in E-GEOD-20524, E-GEOD-4356

Developmental stage
studied in E-GEOD-5668, E-MEXP-1853, E-GEOD-1479, E-GEOD-1867, E-GEOD-4870, ... (22 experiments)

Diet
studied in E-GEOD-16377

dose or concentration
studied in E-GEOD-18858

Family history
studied in E-GEOD-19194

Fraction
studied in E-TABM-363

Generation
studied in E-GEOD-6527

Genotype
studied in E-GEOD-19684, E-MEXP-1649, E-GEOD-2746, E-TABM-285, E-GEOD-19194, ... (32 experiments)

Growth condition
studied in E-GEOD-1867, E-GEOD-1131

Histology
studied in E-GEOD-15904

in vivo treatment
studied in E-GEOD-18858

Individual
studied in E-GEOD-18858

Infection
studied in E-GEOD-17049, E-MEXP-1135, E-MEXP-1942

infection duration (days)
studied in E-GEOD-20524

infection status
studied in E-GEOD-20524

Injury
studied in E-GEOD-1999, E-GEOD-2392

Light
studied in E-TABM-285

Observation
studied in E-GEOD-3594, E-GEOD-5296

Organism
studied in E-MEXP-667

Organism status
studied in E-GEOD-22125

Phenotype
studied in E-GEOD-272, E-GEOD-19979

Protocol type
studied in E-GEOD-16192, E-GEOD-2917

Rna integrity number
studied in E-GEOD-18858

sample preservation
studied in E-GEOD-18858

Sampling time point
studied in E-GEOD-22125

Sex
studied in E-GEOD-6916, E-GEOD-3463, E-GEOD-3530

Stimulus or stress
studied in E-GEOD-15894, E-GEOD-15902, E-GEOD-15901

Strain or line
studied in E-GEOD-21515, E-TABM-562, E-MTAB-76, E-TABM-285, E-GEOD-3248, ... (17 experiments)

Transfect
studied in E-GEOD-6487

Treatment
studied in E-MTAB-76, E-GEOD-18344, E-MEXP-1899, E-MEXP-1375

Treatment repeat
studied in E-GEOD-18858

Treatment time
studied in E-GEOD-18858

Units of amount
studied in E-GEOD-18858

Units of duration
studied in E-GEOD-18858

vehicle for chemical
studied in E-GEOD-18858

Processing time: 0.222 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM